3-Bromo-1-(oxan-2-yl)-1H-pyrazole-5-carbaldehyde

Catalog No. :
ACDLZB654
CAS No. :
2227206-50-8
Molecular Formula :
C9H11BrN2O2
Molecular Weight :
259.10

IUPAC Name:3-bromo-1-(tetrahydro-2H-pyran-2-yl)-1H-pyrazole-5-carbaldehyde

3-Bromo-1-(oxan-2-yl)-1H-pyrazole-5-carbaldehyde structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$61.00Login to see priceIn stockIn stock
250mg97%$99.00Login to see priceIn stockIn stock
1g97%$254.00Login to see priceIn stockIn stock
5g97%$1248.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-Bromo-1-(oxan-2-yl)-1H-pyrazole-5-carbaldehyde
IUPAC Name3-bromo-1-(tetrahydro-2H-pyran-2-yl)-1H-pyrazole-5-carbaldehyde
MDL No.MFCD31618004
Molecular FormulaC9H11BrN2O2
Molecular Weight259.10
SMILESO=CC1=CC(Br)=NN1C2OCCCC2
InChI KeySXQDRDDYWOHUHC-UHFFFAOYSA-N
Synonym3-bromo-1-(oxan-2-yl)-1H-pyrazole-5-carbaldehyde | 2227206-50-8 | 5-bromo-2-(oxan-2-yl)pyrazole-3-carbaldehyde | SCHEMBL23533607 | MFCD31618004 | BS-42999 | P18745 | 3-bromo-1-(tetrahydro-2H-pyran-2-yl)-1H-pyrazole-5-carbaldehyde
CAS No.2227206-50-8
PubChem CID134818882

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACDLZB654 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACVBUF894 route compound structure diagram
    ACVBUF8941044270-96-3 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACDLZB654 route product structure diagram
    ACDLZB6542227206-50-8 In Stock
Inquiry

2. ACDLZB654 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACDLZB654 route product structure diagram
    ACDLZB6542227206-50-8 In Stock
Inquiry

Comments (0)